[et_pb_wpdt_image_card_carousel autoplay=”off” module_class=”illum-resources-box” _builder_version=”4.6.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″][et_pb_wpdt_image_card_carousel_item title=”GDT Publication Booklet” image=”https://illumina.2heads.digital/wp-content/uploads/2022/02/Rectangle-81.svg” open_url=”on” card_url=”https://illumina.2heads.digital/wp-content/uploads/2022/03/GDT-publication-booklet-MGL00605-030322-digital-WGS-RG-U.pdf” _builder_version=”4.6.0″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″]There are an estimated 6–7,000 distinct diseases that meet the definition of rare disease—a number that is growing as new diseases are identified. Epidemiologic studies have estimated that approximately 2 – 6.2% of the population worldwide is affected by rare disease.^1-5[/et_pb_wpdt_image_card_carousel_item][et_pb_wpdt_image_card_carousel_item title=”Illumina Resources medical genome initiative postcard” image=”https://illumina.2heads.digital/wp-content/uploads/2022/02/Rectangle-86.svg” open_url=”on” card_url=”/wp-content/uploads/2022/03/Illumina_Resources_medical-genome-initiative-postcard.pdf” _builder_version=”4.6.0″ _module_preset=”default”]Driving best practices for Whole-genome sequencing (WGS) has the potential to reduce the number of unresolved pediatric rare genetic disease cases.[/et_pb_wpdt_image_card_carousel_item][/et_pb_wpdt_image_card_carousel]